Diabetes MellitusNCT06749535
The Detection of Chronic Obstructive Pulmonary Disease in Patients With Diabetes Mellitus
An observational study of Diabetes Mellitus, run by Superior University at 1 site in Pakistan.
Trial summary
"Background: Chronic obstructive pulmonary disease (COPD) is an ongoing lung condition caused by damage to the lungs. The damage results in swelling and irritation, also called inflammation, inside the airways that limit airflow into and out of the lungs. Diabetes can worsen the progression and prognosis of COPD. Read more about this study
- Who is it for?
- Ages 30 to 65 years
- Conditions the study is for
- Diabetes Mellitus
- What is being tested?
- group 1
- Type of treatment
- Surgery or procedure
- How many people
- 250 participants
- Where
- 1 sitePakistan
- Study dates
- 28 Feb 2024to 2 Mar 2025
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 30 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Aim is to access the Chronic Obstructive Pulmonary Disease in Patients With Diabetes Mellitus
Who may be able to join
- Age: 30-65 years Gender: Both
- Male and female
- At least 5-10 year history of Diabetes Mellitus
- Chronic Obstructive Pulmonary Disease
Who cannot join
- Patients who smoke prolong.
- Patient having other diseased (asthma, lung carcinoma).
- Patients having Acute Respiratory Distress Syndrome (ARDS)."
Trial locations and contacts
1 site in 1 country.
Pakistan1 site
Gulab devi hospital, Ferozepur Rd, Nishtar Town
Lahore, Punjab Province
About this study
"Background: Chronic obstructive pulmonary disease (COPD) is an ongoing lung condition caused by damage to the lungs. The damage results in swelling and irritation, also called inflammation, inside the airways that limit airflow into and out of the lungs. Diabetes can worsen the progression and prognosis of COPD.
Read the detailed description
If inflammation cause in lungs breathing process become disturbed. If damages the air sacs (alveoli) that cause emphysema. COPD mainly starts with asymptomatic patients who do not realize that they have it. It mostly affects older people or middle-aged. Its symptoms become develop slowly but with the time they become worsen, patient change their life style and treatment become helpful to prevent from chronic disease The Detection of Chronic Obstructive Pulmonary Disease in Patients with Diabetes Mellitus.
Methods: The Study design was cross sectional and carried out in hospital, Lahore from July 2024 to Jan 2024. All eligible patients who were Diabetes Mellitus in the study through random sampling technique.
- Conditions
- Diabetes Mellitus
- Being tested
- group 1
- Medical subject headings
- Diabetes Mellitus
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
group 1Radiation
The aim of my study, we should diagnose diabetes on time. If diabetes mellitus untreated or uncontrolled for a long they directly affect all over the body, mostly they caused chronic disease due to hyperglycemia that damages the blood vessels. Rapture or damages the blood vessels of the lung causes COPD.
What is being measured
The primary outcome is the main question the study is designed to answer.
copd
The aim of my study, we should diagnose diabetes on time. If diabetes mellitus untreated or uncontrolled for a long they directly affect all over the body, mostly they caused chronic disease due to hyperglycemia that damages the blood vessels. Rapture or damages the blood vessels of the lung causes COPD.
Measured: 12 Months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Dec 2024
- Study start28 Feb 2024
- Primary completion1 Aug 2024
- Study completion2 Mar 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Diabetes MellitusStudies of the same condition, open and under way.
- More trials run by Superior UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 250 participants (actual)
Sponsor and investigators
- Lead sponsor
- Superior University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Muhammad Naveed Babur, Superior University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06749535
- Sponsor's protocol ID
- MSAHS/Batch-Spring23/039
- Status last verified
- Dec 2024
- First submitted
- 19 Dec 2024
- Last updated
- 27 Dec 2024
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 27 Dec 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Detection of Chronic Obstructive Pulmonary Disease in Patients With Diabetes Mellitus
- ClinicalTrials.gov ID
- NCT06749535
- Acronym / sponsor ID
- MSAHS/Batch-Spring23/039
- Conditions
- Diabetes Mellitus
- Study type
- Observational
- Recruitment status
- Active, not recruiting
- Enrolment
- 250 participants (actual)
- Lead sponsor
- Superior UniversityUniversity, hospital or other
- Study start
- 28 Feb 2024 (actual)
- Primary completion
- 1 Aug 2024 (actual)
- Study completion
- 2 Mar 2025 (estimated)
- First posted
- 27 Dec 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
"Background: Chronic obstructive pulmonary disease (COPD) is an ongoing lung condition caused by damage to the lungs. The damage results in swelling and irritation, also called inflammation, inside the airways that limit airflow into and out of the lungs. Diabetes can worsen the progression and prognosis of COPD.
Detailed description
If inflammation cause in lungs breathing process become disturbed. If damages the air sacs (alveoli) that cause emphysema. COPD mainly starts with asymptomatic patients who do not realize that they have it. It mostly affects older people or middle-aged. Its symptoms become develop slowly but with the time they become worsen, patient change their life style and treatment become helpful to prevent from chronic disease The Detection of Chronic Obstructive Pulmonary Disease in Patients with Diabetes Mellitus.
Methods: The Study design was cross sectional and carried out in hospital, Lahore from July 2024 to Jan 2024. All eligible patients who were Diabetes Mellitus in the study through random sampling technique.
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 30 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Aim is to access the Chronic Obstructive Pulmonary Disease in Patients With Diabetes Mellitus
Key inclusion criteria (4 listed)
- Age: 30-65 years Gender: Both
- Male and female
- At least 5-10 year history of Diabetes Mellitus
- Chronic Obstructive Pulmonary Disease
Key exclusion criteria (3 listed)
- Patients who smoke prolong.
- Patient having other diseased (asthma, lung carcinoma).
- Patients having Acute Respiratory Distress Syndrome (ARDS)."
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| group 1The aim of my study, we should diagnose diabetes on time. If diabetes mellitus untreated or uncontrolled for a long they directly affect all over the body, mostly they caused chronic disease due to hyperglycemia that damages the blood vessels. Rapture or damages the blood vessels of the lung causes COPD. | Radiation | – |
Primary outcome
copd
Time frame: 12 Months
The aim of my study, we should diagnose diabetes on time. If diabetes mellitus untreated or uncontrolled for a long they directly affect all over the body, mostly they caused chronic disease due to hyperglycemia that damages the blood vessels. Rapture or damages the blood vessels of the lung causes COPD.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Dec 2024.
- Individual participant dataSharing planned: No
Related trials for Diabetes Mellitus
Not yet recruitingPhase 3
Efficacy and Safety of Once-Weekly SHR-3167 Compared With Once-Daily Insulin Glargine in Adults With Insulin-Naive Type 2 Diabetes
Type 2 Diabetes
Active, not recruiting
Digital Reinforcement of Motivational Interviewing Micro-Skills Among Primary Care Healthcare Professionals
Hypertension (Without Type 2 Diabetes Mellitus)
Recruiting
Effects of Lean Pork Loin Intake on Protein Homeostasis and Glucose Regulation in Prediabetic Adults
Hyperglycaemia (Non Diabetic), Prediabetes
Recruiting
PAW-Hydrogel for Chronic Wound Healing
Diabetic Foot Ulcer (DFU), Pressure Ulcer (PU)
Recruiting
Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease
Chronic Kidney Disease, Hypertension (HTN)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Diabetes Mellitus, run by Superior University at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 27 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
copd (time frame: 12 Months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Dec 2024.